DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Spiriva (Tiotropium Bromide Monohydrate Inhalation) - Current Clinical Trials

 
 



Spiriva Related Clinical Trials

Dynamic Hyperinflation and Tiotropium [Completed]

A Study of Arformoterol Tartrate Inhalation Solution and Tiotropium Bromide on Re-hospitalization in Chronic Obstructive Pulmonary Disease (COPD) Subjects [Recruiting]

Blacks and Exacerbations on Long Acting Beta Agonists (LABA) vs. Tiotropium (BELT) [Completed]

Study to Evaluate the Effects of Tiotropium Bromide on Chronic Obstructive Pulmonary Disease (COPD) During Exercise [Completed]

A Study of 3 Doses of Tiotropium Hydrofluoralkane (HFA) Breath Actuated Inhaler (BAI), in Patients With Chronic Obstructive Pulmonary Disease [Withdrawn]

Efficacy in Walked Distance of Indacaterol vs Tiotropium in Women With COPD Secondary to Biomass (EMERALD) [Recruiting]

Comparison of Indacaterol With That of Placebo in 'Maintenance naïve' Patients With COPD Using Blinded Tiotropium as Active Control [Withdrawn]

Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD) [Completed]

The Effects of Tiotropium on the Cough Reflex in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS 250/50mcg Plus SPIRIVA HANDIHALER Versus SPIRIVA HANDIHALER Plus Placebo DISKUS in Subjects With Chronic Obstructive Pulmonary Disease (COPD). SPIRIVA and HANDIHALER Are Trade Marks of Boehringer Ingelheim [Completed]

Evaluation of Efficacy and Safety of Symbicort« as an add-on Treatment to Spiriva« in Patients With Severe COPD. [Completed]

Spiriva« in Patients With Chronic Obstructive Pulmonary Disease (COPD) in Daily Practice [Completed]

Spiriva« in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

A Study to Characterize Pharmacokinetics of Tiotropium + Olodaterol Fixed-dose Combination in Japanese Patients With COPD. [Completed]

Add-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease Patients [Completed]

Effect of Spiriva« 18 Microgram on Health-related Quality of Life and Physical Functioning in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Proven Hyperinflation [Completed]

Combination of Orally Inhaled BI1744CL/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease ( COPD) [Completed]

Effects of Tiotropium on Walking Capacity in Patients With COPD [Completed]

24-hour Lung Function in Subjects With Moderate to Very Severe COPD After Treatment With PT003, Open-Label Spiriva´┐Ż Respimat´┐Ż as an Active Control, and Placebo [Active, not recruiting]

Tiotropium Induced Bronchodilation in Lung CT Scored Emphysema [Completed]

Tiotropium/Salmeterol Inhalation Powder (Spiriva Handihaler and Salmeterol PE Capsule) in COPD [Terminated]

Cardiac Limitations in Chronic Obstructive Pulmonary Disease: Benefits of Bronchodilation [Completed]

Tiotropium Respimat Pharmacokinetic Study in COPD [Completed]

Tiotropium/Salmeterol Inhalation Powder in COPD [Terminated]

Safety and Efficacy of 12-wk Treatment With Two Doses of Tiotropium Respimat in Cystic Fibrosis [Completed]

A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD) [Completed]

PT001 MDI Versus Spiriva« in Patients With Moderate to Severe COPD [Completed]

A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium Compared With Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease [Completed]

Comparative Study of Umeclidinium/Vilanterol (UMEC/VI) in a Fixed Dose Combination With Indacaterol Plus Tiotropium [Completed]

Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients. [Completed]

Tiotropium in Combination With Concomitant Cimetidine or Ranitidine in Healthy Male and Female Subjects [Completed]

Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva« Handihaler« (PINNACLE 3) [Completed]

Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients [Completed]

Indacaterol Versus Tiotropium on Dynamic Hyperinflation in COPD [Completed]

Effect of Spiriva on the Activities of Daily Living Score Recommended in Austrian COPD Guidelines [Completed]

Study to Evaluate the Safety and Efficacy of Inhaled PT001 in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Tiotropium Respimat Versus HandiHaler on SaO2 and Sleep in COPD Patients [Completed]

Evaluation of Tiotropium 2.5 and 5 ┬Ág Once Daily Delivered Via the Respimat Inhaler Compared to Placebo in Patient With Moderate to Severe Persistent Asthma [Completed]

Pharmacokinetics of the Fixed Dose Combination of Tiotropium Plus BI 54903 Versus the Combination of the Monoproducts of Tiotropium and BI 54903 in Healthy Volunteers [Completed]

Characterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary Disease [Completed]

Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease [Completed]

Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease [Completed]

Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease [Completed]

SPIRIVA in Ususal Care [Completed]

Specific Use-result Surveillance of Spiriva Respimat in Asthmatics [Recruiting]

Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC) [Completed]

Efficacy and Safety of Ba679BR Powder Inhalation in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

The Study Will Evaluate the Effect of AZD9164 in Patients With Chronic Obstructive Pulmonary Disease [Completed]

Japan Long-term Safety for Tiotropium Plus Olodaterol [Completed]

Efficacy, Safety, and Tolerability of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

A 3 Way Cross-over Study Evaluating the Effects of ADOAIR Twice Daily Plus Tiotropium Bromide Once Daily Compared With the Individual Treatments of Japanese Subjects [Completed]

The Effect of QVA149 on Patient Reported Dyspnea in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Tiotropium and Salmeterol PK Study in COPD Patients [Completed]

Study to Evaluate the Effect on Lung Function and ECG When a Combination of Tiotropium Plus Olodaterol is Administered to Patients With COPD Either From a Single Inhaler or Each Compound is Administered After Each Other From Two Different Inhalers [Completed]

A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD [Recruiting]

24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease [Completed]

24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease [Completed]

Randomised, Double- Blind, Cross-over Efficacy and Safety Comparison of Three Different Doses of Tiotropium Administered Once Daily Versus Placebo in Patients With Moderate Persistent Asthma. [Completed]

Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

The Effect of QVA149 on Health Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Tiotropium In Exercise [Completed]

Effects of Tiotropium on Breathing Capacity and Exercise Limitation in Early Stages of Chronic Obstructive Pulmonary Disease [Completed]

Multiple Dose Comparison of Tiotropium Inhalation Capsules, Salmeterol Inhalation Aerosol and Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Tiotropium for Smoking Asthmatics Study [Withdrawn]

RUSSE / Russian Spiriva« Safety & Efficacy Study [Completed]

Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate in Chronic Obstructive Pulmonary Disease [Active, not recruiting]

Comparative Pharmacokinetics and Pharmacodynamics of Tiotropium With Ipratropium or Placebo After 19 Days of Tiotropium Treatment [Completed]

Evaluation of Tiotropium 5 ┬Ág/Day Delivered Via the Respimat« Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study II) [Completed]

Spiriva´┐Ż Assessment of FEV1 (SAFE) [Completed]

Efficacy and Safety of 2 Doses of Tiotropium Via Respimat in Adult Patients With Mild Persistent Asthma [Completed]

Determining Optimal Free Dose Combination of Tiotropium Bromide and BI 1744 CL in Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Co-administration of Olodaterol Respimat« and Tiotropium Handihaler« [Completed]

Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Tiotropium Bromide Inhalation Powder 18mcg Once Daily in Subjects With COPD Who Have or Are At Risk for Co-morbid Cardiovascular Disease [Completed]

Glycopyrrolate/Formoterol Fumarate MDI Compared With Spiriva« as An Active Control in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease [Completed]

Closing Volume Interpretation and Bronchodilators Effect [Completed]

A Study to Determine the Effect of Tiotropium + Olodaterol Fixed Dose Combination on Exercise Endurance Time During Constant Work Load Cycle Test in COPD [Completed]

Evaluation of Tiotropium 5 ┬Ág/Day Delivered Via the Respimat« Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study I) [Completed]

Outcomes and Costs Associated With Initiating Maintenance Treatment With Fluticasone Propionate 250mcg/Salmeterol Xinafoate 50mcg Combination (FSC) Versus Anticholinergics Including Tiotropium (TIO) in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Safety, Tolerability and Pharmacodynamics of QAX028 Compared to Open-label Tiotropium Bromide and Placebo in Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD) Patients. [Completed]

Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD); (PINNACLE 1) [Completed]

Co-administration of Olodaterol Respimat« and Tiotropium Handihaler« [Completed]

Bronchodilators and Respiratory Mechanics in Chronic Obstructive Pulmonary Disease (COPD) Patients [Terminated]

Dose Tolerance Study After Ocular Administration of Tiotropium in Healthy Male Volunteers [Completed]

Effect of Spiriva« on Health-related Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients Who Stopped Smoking During Treatment. [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015